Media release: RCA welcomes life-saving investment in genomic testing and clinical trial development
March 17, 2022
Rare Cancers Australia (RCA) welcomes the Government’s $61.2 million funding commitment announced today for Omico’s Project, PrOSPeCT.
Read more arrow_forward